SaneVax: Why is a highly sensitive HPV test used in vaccine development and not for patient care?

July 12, 2012 By Leave a Comment
Sanevax-square

By Norma Erickson, President The SaneVax Team wants to know why consultants paid by the pharmaceutical industry appear to be using the World Health Organization (WHO) and the National Cancer Institute (NCI) to promote a double standard of HPV testing to market “cervical cancer vaccines” at the expense of women’s health. Are HPV vaccine manufacturers, [...]

[Continue reading...]
Filed Under: HPV Testing, SANE Vax Press Releases, United States Tagged With: , ,

Post-HPV Vaccination Tests

September 6, 2011 By

Should you experience an abnormal Pap smear after HPV vaccination, it is important to know what genotype of HPV is present in the abnormal cells. Should the HPV be a vaccine-relevant genotype, the vaccine that was administered to you did not clear the HPV already in your body. You may need closer Pap test screening. [...]

[Continue reading...]
Filed Under: Post-HPV Vaccination Tagged With: , , ,

High prevalence of human papillomavirus type 16 infection among children

June 17, 2011 By Leave a Comment

Refdoc.fr Auteur(s) / Author(s) RICE P. S. (1 2) ; MANT C. (1 2) ; CASON J. (1 2) ; BIBLE J. M. (1 2) ; MUIR P. (1 2) ; KELL B. (1 2) ; BEST J. M. (1 2) Affiliation(s) du ou des auteurs / Author(s) Affiliation(s) (1) Richard Dimbleby Laboratory of Cancer Virology, Department of Infection, Guy’s, King’s College, [...]

[Continue reading...]
Filed Under: Cervical Cancer, HPV Testing, Science & Medicine, Vaccine Science Tagged With: , , , , ,

Human papillomavirus in the placenta and umbilical cord blood.

June 17, 2011 By Leave a Comment

PubMed.gov Acta Obstet Gynecol Scand. 2008;87(11):1181-8. Sarkola ME, Grénman SE, Rintala MA, Syrjänen KJ, Syrjänen SM. Source Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland. marja.sarkola@utu.fi Abstract OBJECTIVE: To analyze human papillomavirus (HPV) DNA in umbilical cord blood and in placenta, including its cellular localization. DESIGN: Longitudinal prospective study. SETTING: Maternity Unit [...]

[Continue reading...]
Filed Under: HPV Science, HPV Testing, Vaccine Science Tagged With: , , ,

3 year gap in between Pap tests, apparently ok

June 6, 2011 By Leave a Comment

VIHC Vaccine Injury Help Center June 1, 2011 Most women aged 30 and older with normal Pap and human papillomavirus (HPV) test results can safely wait three years until their next set of cervical cancer screening tests, according to a new study discussed in an article written for WebMD Health News, published on May 18, [...]

[Continue reading...]
Filed Under: Cervical Cancer, HPV Testing, Pap Testing, Vaccine Politics/People, Vaccine Science Tagged With: , ,